Hypera Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Breno Pires de Oliveira

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	no data
Participación del CEO	n/a
Permanencia media de la dirección	sin datos
Promedio de permanencia en la Junta Directiva	9.1yrs

Actualizaciones recientes de la dirección

Recent updates

More Unpleasant Surprises Could Be In Store For Hypera S.A.'s (BVMF:HYPE3) Shares After Tumbling 27%

Nov 21

Hypera S.A.'s (BVMF:HYPE3) Popularity With Investors Is Under Threat From Overpricing

Jun 20

Hypera S.A. (BVMF:HYPE3) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Mar 16

Is Hypera (BVMF:HYPE3) A Risky Investment?

Feb 21

Here's Why Hypera (BVMF:HYPE3) Has Caught The Eye Of Investors

Jan 09

Hypera S.A.'s (BVMF:HYPE3) Business Is Yet to Catch Up With Its Share Price

Dec 22

Hypera (BVMF:HYPE3) Has A Somewhat Strained Balance Sheet

Nov 02

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

Aug 27

Is Hypera (BVMF:HYPE3) A Risky Investment?

Jul 21

We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

Apr 15

With EPS Growth And More, Hypera (BVMF:HYPE3) Makes An Interesting Case

Feb 19

We Think Hypera (BVMF:HYPE3) Can Stay On Top Of Its Debt

Jan 03

Is Now The Time To Put Hypera (BVMF:HYPE3) On Your Watchlist?

Oct 11

Hypera S.A. (BVMF:HYPE3) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Jul 31

Is Hypera (BVMF:HYPE3) Using Too Much Debt?

Jul 19

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

Jun 28

Here's Why Hypera (BVMF:HYPE3) Can Manage Its Debt Responsibly

Apr 14

I Ran A Stock Scan For Earnings Growth And Hypera (BVMF:HYPE3) Passed With Ease

Mar 25

Subdued Growth No Barrier To Hypera S.A.'s (BVMF:HYPE3) Price

Mar 04

CEO

Breno Pires de Oliveira (49 yo)

no data

Permanencia

Mr. Breno Toledo Pires De Oliveira serves as Chief Executive Officer of Hypera S.A. and served as its Director. Previously, he served as Chief Financial Officer and Investor Relations Officer at HYPERA S.A...

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Esteban Malpica Fomperosa	Non-Executive Director	18.1yrs	sin datos	sin datos
Bernardo Malpica Hernández	Non-Executive Director	18.1yrs	sin datos	sin datos
Luciana Fleischner Alves de Queiroz	Non-Executive Director	18.1yrs	sin datos	sin datos
Marcelo Curti	Member of Fiscal Council	12.1yrs	sin datos	sin datos
Mauro Stacchini	Member of Fiscal Council	9.1yrs	sin datos	sin datos
Maria Ferreira Lacerda	Non-Executive Independent Director	8.1yrs	sin datos	sin datos
Hugo Sodré Leal	Non-Executive Director	6.1yrs	sin datos	sin datos
Alvaro Link	Chairman	11.1yrs	sin datos	sin datos
Flair Carrilho	Non-Executive Independent Director	6.1yrs	sin datos	sin datos
Eliana Helena de Ambrosio Chimenti	Independent Director	2.1yrs	sin datos	sin datos
Mauro Gentile da Cunha	Independent Director	2.1yrs	sin datos	sin datos
Roberto Flesch	Member of Fiscal Council	9.1yrs	sin datos	sin datos

9.1yrs

Permanencia media

56yo

Promedio de edad

Junta con experiencia: La junta directiva de HYPE3 se considera experimentada (9.1 años de antigüedad promedio).

Análisis de la empresa y estado de los datos financieros

Datos	Última actualización (huso horario UTC)
Análisis de la empresa	2025/02/06 10:49
Precio de las acciones al final del día	2025/02/06 00:00
Beneficios	2024/09/30
Ingresos anuales	2023/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

Paquete	Datos	Marco temporal	Ejemplo Fuente EE.UU. ^*
Finanzas de la empresa	10 años	Cuenta de resultados Estado de tesorería Balance	Formulario SEC 10-K Formulario SEC 10-Q
Estimaciones del consenso de analistas	+3 años	Previsiones financieras Objetivos de precios de los analistas	Informes de análisis Blue Matrix
Precios de mercado	30 años	Precios de las acciones Dividendos, escisiones y acciones	Datos de mercado ICE Formulario S-1 de la SEC
Propiedad	10 años	Accionistas principales Información privilegiada	Formulario SEC 4 Formulario SEC 13D
Gestión	10 años	Equipo directivo Consejo de Administración	Formulario SEC 10-K Formulario SEC DEF 14A
Principales avances	10 años	Anuncios de empresas	Formulario SEC 8-K

^* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Hypera S.A. está cubierta por 31 analistas. 13 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

Analista	Institución
Andréa Aznar	BB Banco de Investimento S.A.
Georgia Jorge	BB Banco de Investimento S.A.
Robert Ford Aguilar	BofA Global Research

Hypera Dirección

Dirección controles de criterios 1/4

Información clave

Actualizaciones recientes de la dirección

Hypera S.A., Annual General Meeting, Apr 23, 2024

Less than half of directors are independent

Less than half of directors are independent

Hypera S.A., Annual General Meeting, Apr 26, 2022

Recent updates

Hypera S.A. to Report Q3, 2025 Results on Oct 29, 2025

Price target decreased by 8.1% to R$27.83

Hypera S.A. to Report Fiscal Year 2024 Results on Mar 20, 2025

More Unpleasant Surprises Could Be In Store For Hypera S.A.'s (BVMF:HYPE3) Shares After Tumbling 27%

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

Price target decreased by 8.4% to R$33.76

Consensus EPS estimates fall by 11%

Investors Appear Satisfied With Hypera S.A.'s (BVMF:HYPE3) Prospects

Second quarter 2024 earnings: EPS exceeds analyst expectations

We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

Now 27% undervalued after recent price drop

Now 22% undervalued after recent price drop

Hypera S.A.'s (BVMF:HYPE3) Popularity With Investors Is Under Threat From Overpricing

Now 23% undervalued after recent price drop

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 21% undervalued after recent price drop

Hypera S.A., Annual General Meeting, Apr 23, 2024

Hypera S.A. (BVMF:HYPE3) Just Reported Annual Earnings: Have Analysts Changed Their Mind On The Stock?

Full year 2023 earnings: EPS and revenues miss analyst expectations

Is Hypera (BVMF:HYPE3) A Risky Investment?

Hypera S.A. to Report Q3, 2024 Results on Nov 06, 2024

Here's Why Hypera (BVMF:HYPE3) Has Caught The Eye Of Investors

Hypera S.A.'s (BVMF:HYPE3) Business Is Yet to Catch Up With Its Share Price

Hypera (BVMF:HYPE3) Has A Somewhat Strained Balance Sheet

Third quarter 2023 earnings: EPS exceeds analyst expectations

Now 21% undervalued after recent price drop

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

New major risk - Financial position

Second quarter 2023 earnings released: EPS: R$0.79 (vs R$0.72 in 2Q 2022)

Is Hypera (BVMF:HYPE3) A Risky Investment?

First quarter 2023 earnings released

We Think Hypera (BVMF:HYPE3) Is Taking Some Risk With Its Debt

With EPS Growth And More, Hypera (BVMF:HYPE3) Makes An Interesting Case

Full year 2022 earnings released: EPS: R$2.69 (vs R$2.56 in FY 2021)

Hypera S.A. to Report Q4, 2022 Results on Feb 16, 2023

We Think Hypera (BVMF:HYPE3) Can Stay On Top Of Its Debt

Less than half of directors are independent

Third quarter 2022 earnings released

Is Now The Time To Put Hypera (BVMF:HYPE3) On Your Watchlist?

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Hypera S.A. (BVMF:HYPE3) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year

Is Hypera (BVMF:HYPE3) Using Too Much Debt?

Hypera Reportedly in Merger Talks with Grupo NC

Hypera S.A. to Report Q3, 2022 Results on Oct 28, 2022

Do Hypera's (BVMF:HYPE3) Earnings Warrant Your Attention?

First quarter 2022 earnings: Revenues in line with analyst expectations

Less than half of directors are independent

Hypera S.A. to Report Q1, 2022 Results on Apr 28, 2022

Here's Why Hypera (BVMF:HYPE3) Can Manage Its Debt Responsibly

Hypera S.A., Annual General Meeting, Apr 26, 2022

I Ran A Stock Scan For Earnings Growth And Hypera (BVMF:HYPE3) Passed With Ease

Subdued Growth No Barrier To Hypera S.A.'s (BVMF:HYPE3) Price

Full year 2021 earnings: EPS exceeds analyst expectations

Hypera S.A. to Report Fiscal Year 2021 Results on Feb 24, 2022

Hypera S.A.(BOVESPA:HYPE3) dropped from Brazil Valor BM&FBOVESPA Index

Third quarter 2021 earnings released: EPS R$0.73 (vs R$0.56 in 3Q 2020)

Second quarter 2021 earnings released

First quarter 2021 earnings released: EPS R$0.48 (vs R$0.39 in 1Q 2020)

New 90-day low: R$30.52

Full year 2020 earnings released

Revenue and earnings beat expectations

Hypera S.A. to Report Q4, 2020 Results on Feb 26, 2021

New 90-day high: R$35.31

New 90-day high: R$32.34

Market bids up stock over the past week

New 90-day low: R$28.80

Third quarter earnings released

Third-quarter earnings released: Revenue and earnings beat expectations

New 90-day low: R$30.22

Hypera S.A. (BOVESPA:HYPE3) completed the acquisition of Boehringer Ingelheim Buscopan brand and other assets from Boehringer Ingelheim International Gmbh, Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda. and Boehringer Ingelheim Pharma GmbH & Co. KG.